1018

Leu-enkephalin Mouse Monoclonal Antibody (NOC1)

Application :

ICC, IHC, RIA

Reactivity :

Human, Rat

Host :

Mouse

Clonality :

Monoclonal

USD $449.44

/ 0.5 mL

Additional information

Weight 0.03 lbs
Dimensions 0.3 × 0.25 × 0.1 in

Overview

Target

Leu-enkephalin

Target background

Enkephalins (penta-peptides) have been discovered as regulators of nerve impulses involving pain in the brain. It has been shown that these peptides act as natural analgesics (pain-killers) and their action mimics that of morphine and other opiates. At present, it is thought that the morphine-like effects are due to aromatic side chains on phenylanine and tyrosine which mimic a similar structure on morphine. Research suggests that it does not make much difference whether the enkephalin contains methionine or leucine at the acid end of the peptide for its action.

Target alias

Enkephalin, endorphins, endorphin, Met5-enkephalin, Leu5-enkephalin, Met-enkephalin, Leu-enkephalin, anti-Enkephalin, anti-endorphins, anti-endorphin, anti-Met5-enkephalin, anti-Leu5-enkephalin, anti-Met-enkephalin, anti-Leu-enkephalin

Immunogen

pentapeptide ( Tyr-Gly-Gly-Phe-Leu)

Specificity

A sensitive antibody against enkephalinergic fibrilar networks in the globus pallidus, N. accumbens, septum, hypothalamus, thalamus, amygdala, N. interstitialis of the stria terminalis and brain stem nuclei. This antibody does not distinguish between Met5-enkephalin and Leu5-enkephalin by radioimmunoassay or by immunocytochemistry. It is recommended for localizing enkephalinergic sites by immunohistochemistry. It does not bind to beta-endorphin or dynorphin-containing areas. It exhibits approximately. 40% cross reactivity with c-terminal extended Met-enkephalin hexapeptides and 7% cross reactivity with the extended heptapeptide (-Arg-Phe-0H), but does not recognize other endogenous peptides. All wellestablished enkephalin immunoreactive sites are recognized by this antibody in immunohistochemistry (IHC) and electron microscopy immunocytochemistry (ICC). Specific for: rat and human

Clone ID

NOC1

Isotype

IgG1

Preservative

0.05% thimerosal (Thimerosal-free version, MM-1018)

Format

Lyophilized tissue culture supernatant

Recommend starting dilution

If reconstituted with deionized water in 0.5 mL: IHC 1:100 - 1:400. Optimal dilution has to be determined by the user.

Limitations

Research Use Only

Storage

Lyophilized antibodies can be kept at 4ºC for up to 3 months and should be kept at -20ºC for long-term storage (2 years). To avoid freeze-thaw cycles, reconstituted antibodies should be aliquoted before freezing for long-term (1 year) storage (-80ºC) or kept at 4ºC for short-term usage (2 months). For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made with the assay buffer. After the maximum long-term storage period (2 years lyophilized or 1 year reconstituted) antibodies should be tested in your assay with a standard sample to verify if you have noticed any decrease in their efficacy. To limit antibody loss or degradation, BSA (final concentration 1%) and sodium azide (final concentration 0.02%) can be added to the suggested first dilution. It is important to first verify if those preservatives are compatible with your assay.

Product datasheet

Leu-enkephalin Mouse Monoclonal Antibody (NOC1)

SKU: 1018
0.5 mL

Overview

Target

Leu-enkephalin

Target background

Enkephalins (penta-peptides) have been discovered as regulators of nerve impulses involving pain in the brain. It has been shown that these peptides act as natural analgesics (pain-killers) and their action mimics that of morphine and other opiates. At present, it is thought that the morphine-like effects are due to aromatic side chains on phenylanine and tyrosine which mimic a similar structure on morphine. Research suggests that it does not make much difference whether the enkephalin contains methionine or leucine at the acid end of the peptide for its action.

Target alias

Enkephalin, endorphins, endorphin, Met5-enkephalin, Leu5-enkephalin, Met-enkephalin, Leu-enkephalin, anti-Enkephalin, anti-endorphins, anti-endorphin, anti-Met5-enkephalin, anti-Leu5-enkephalin, anti-Met-enkephalin, anti-Leu-enkephalin

Immunogen

pentapeptide ( Tyr-Gly-Gly-Phe-Leu)

Specificity

A sensitive antibody against enkephalinergic fibrilar networks in the globus pallidus, N. accumbens, septum, hypothalamus, thalamus, amygdala, N. interstitialis of the stria terminalis and brain stem nuclei. This antibody does not distinguish between Met5-enkephalin and Leu5-enkephalin by radioimmunoassay or by immunocytochemistry. It is recommended for localizing enkephalinergic sites by immunohistochemistry. It does not bind to beta-endorphin or dynorphin-containing areas. It exhibits approximately. 40% cross reactivity with c-terminal extended Met-enkephalin hexapeptides and 7% cross reactivity with the extended heptapeptide (-Arg-Phe-0H), but does not recognize other endogenous peptides. All wellestablished enkephalin immunoreactive sites are recognized by this antibody in immunohistochemistry (IHC) and electron microscopy immunocytochemistry (ICC). Specific for: rat and human

Clone ID

NOC1

Isotype

IgG1

Preservative

0.05% thimerosal (Thimerosal-free version, MM-1018)

Format

Lyophilized tissue culture supernatant

Recommend starting dilution

If reconstituted with deionized water in 0.5 mL: IHC 1:100 - 1:400. Optimal dilution has to be determined by the user.

Limitations

Research Use Only

Storage

Lyophilized antibodies can be kept at 4ºC for up to 3 months and should be kept at -20ºC for long-term storage (2 years). To avoid freeze-thaw cycles, reconstituted antibodies should be aliquoted before freezing for long-term (1 year) storage (-80ºC) or kept at 4ºC for short-term usage (2 months). For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made with the assay buffer. After the maximum long-term storage period (2 years lyophilized or 1 year reconstituted) antibodies should be tested in your assay with a standard sample to verify if you have noticed any decrease in their efficacy. To limit antibody loss or degradation, BSA (final concentration 1%) and sodium azide (final concentration 0.02%) can be added to the suggested first dilution. It is important to first verify if those preservatives are compatible with your assay.
Change my preferences
+

We use cookies to facilitate your navigation and enable certain features. You can see detailed information about all cookies in each consent category below.

Functional cookies (Required)

These cookies are essential for the proper functioning of our website; that’s why you can’t delete them.

Statistical cookies

These cookies allow us to know the use made of our site and its performance, to establish usage statistics and to determine the volumes of attendance and use of the various elements.

Advertising cookies

These cookies are used to provide visitors with personalized advertisements based on previously visited pages and to analyze the effectiveness of the advertising campaign.

Reject
Confirm my selection
Cookies

This site uses cookies, deposited by our website, in order to improve your browsing experience. For more information on the purposes and to customize your preferences by type of cookies used, please visit our privacy policy page.

Accept all
Manage my preferences